The Digital Executive
Myth and Reality in AI with Founder John Thomas Foxworthy | Ep 1003
24 Jan 2025
Send us a text In this episode of The Digital Executive Podcast, host Brian Thomas sits down with John Thomas Foxworthy, founder of the Global Institute of Data Science and a fractional Chief AI Officer of Turing Forge. With two decades of AI and machine learning expertise, Foxworthy delves into the elusive nature of human consciousness and its role—or lack thereof—in artificial intelligence. He explains why true machine consciousness remains a distant dream and highlights how marketing hype often overshadows the science behind AI. Foxworthy also provides valuable insights into entering the AI field, debunking myths about the necessity of advanced coding skills or PhDs. He explores the advantages of no-code platforms, the evolving role of startups, and the industry’s bias toward manual coding. Packed with practical advice and candid industry observations, this episode is a must-listen for anyone curious about AI's future and how to navigate this dynamic field. Tune in to hear the unfiltered perspective of a true AI expert!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare